Apotex Wants Sanctions In Generic-Lipitor Labeling Suit

By Michael Lipkin (October 29, 2014, 8:22 PM EDT) -- Drug manufacturer Apotex Corp. on Wednesday slammed a consumer's suit that accused it of selling generic versions of Lipitor imported from India without proper labeling, saying the drugs were actually made in Canada and seeking sanctions in California federal court for the allegedly frivolous complaint.  

Made in the U.S.A. Foundation Chairman Joel D. Joseph's suit against Apotex and Costco Wholesale Corp. claimed Apotex's version of the cholesterol medication, known as atorvastatin, was manufactured in India without country-of-origin labeling and was banned by the U.S. Food and Drug Administration. Joseph claimed the FDA tagged an Indian Apotex factory for a failure to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!